5 reasons to call in the experts: Establishing a pharma business in Australia
Commercial Eyes has assisted a number of companies to establish a pharma business in Australia, so what are 5 reasons to call in the…
Delivering strategic insights, competitive intelligence and developing and driving HTA strategy to maximise market opportunities.
Determining strategic solutions with impactful results
At Commercial Eyes, we utilise our specialised market Access, Research and Intelligence skills to help your brand achieve commercial success by being accessible to as many patients as possible. We do this by identifying your product’s value from a payer perspective and by determining its value proposition with key stakeholders.
The Commercial Eyes Access, Research & Intelligence (ARI) team consists of experienced commercialisation consultants, including specialists in market access, market research and market intelligence. We offer a holistic approach to new product planning, market assessment, developing health technology assessment (HTA) strategies and submissions and advice and analysis on pricing and related policies for medicines, devices and diagnostics.
Our consultants have a practical and thorough understanding of the Australian and New Zealand healthcare environment backed by sound technical skills, knowledge and experience.
We move beyond simple solutions, we delve deeper to uncover genuine insights and deliver high-quality outcomes to help you make strategic decisions, identify and evaluate new business opportunities and maximise patient access for your products.
We can help you
The Commercial Eyes Access, Research and Intelligence (ARI) team provides a comprehensive array of services for health technologies across all stages of the product lifecycle. With an unwavering commitment to innovation, we’ve recently launched an innovation arm to keep us at the forefront of global trends. Our portfolio of projects is diverse, commissioned by start-ups, sponsors, and distributors across the healthcare spectrum. From guiding MedTech start-ups to groundbreaking biosimilars, COVID-19 therapeutics, diagnostics, and pioneering cell and gene therapies, we navigate various levels of innovation to meet your unique needs.
Our experienced Access team can help you navigate the complexities of reimbursement and policy frameworks, ensuring optimal market access and successful product launches in Australia and New Zealand. We provide comprehensive support for your products, encompassing:
Our team of research and intelligence specialists excels in crafting bespoke research solutions tailored to address your unique challenges and objectives. From patient journey mapping to competitor intelligence reports, we deliver comprehensive and insightful analyses to inform your strategic decisions. Our adept market research experts employ a variety of qualitative and quantitative methodologies, coupled with advanced statistical analysis, to address your inquiries and provide actionable insights regarding your market, product, competitors, and customers. Our certified Intelligence professionals can help your organisation or brand team gain a perspective on evolving market dynamics, discerning strategic opportunities, and identifying potential risks for your brand or organisation. This empowers you to assess your value proposition, anticipate competitor movements, and safeguard your plans against competitive threats. Our suite of services includes:
Our innovation team helps companies navigate and capitalise on both local and global trends, empowering them to respond effectively and leverage the latest approaches in service design, technology, data utilisation, and commercialisation. The team can assist you with:
Clients across the globe
Major HTA submissions undertaken on average per year
Access, Research & Intelligence projects undertaken in the past 12 months